INSIGHTS ON CLINICAL TRIAL PARTNERING

• How Sponsors, CROs, And Tech Vendors Can Reduce Site Tech Overload

  Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.

• Five Ways Site-Facing Technology Helps Sponsors And CROs

  Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.

• How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work

  Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.

• How A Strategic Bioanalysis CRO Partnership Empowers Sponsors

  Choosing the right bioanalysis CRO is vital to avoid costly delays. Sponsors need evaluation strategies that prioritize proven quality, predictable timelines, and submission-ready data.

• Addressing A Global Health Priority In Australia And New Zealand

  11/7/2025

  For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.

• Making The Lives Of Patients And Research Sites Easier

  5/14/2025

  Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.

• Setting A New Client Standard In Study Closeout Timelines

  4/4/2025

  Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.

• Step Inside IQVIA One Home for Sites™

  1/28/2025

  Whether you're a sponsor, site, or technology vendor, now is the time to embrace One Home and join this industry-wide collaboration.

• The Real Power Of Digital Payments In Clinical Trials

  10/8/2025

  Digital payments streamline clinical trials by reducing site burden, improving patient experience, eliminating manual delays, and delivering cleaner data across global studies.